Literature DB >> 7039925

Therapeutic drug monitoring of antiarrhythmic agents.

J E Brown, D G Shand.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 7039925     DOI： 10.2165/00003088-198207020-00003

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  140 in total

1.  Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia.

Authors:  R E Rangno; W Warnica; R I Ogilvie; J Kreeft; E Bridger
Journal:  J Int Med Res       Date:  1976       Impact factor: 1.671

2.  Acute termination of cardiac arrhythmias with intravenous disopyramide.

Authors:  H F Mizgala; P R Huvelle
Journal:  J Int Med Res       Date:  1976       Impact factor: 1.671

Review 3.  Clinical applications of the pharmacokinetics of lidocaine.

Authors:  N L Benowitz
Journal:  Cardiovasc Clin       Date:  1974

4.  The convulsant potency of lidocaine and its N-dealkylated metabolites.

Authors:  J Blumer; J M Strong; A J Atkinson
Journal:  J Pharmacol Exp Ther       Date:  1973-07       Impact factor: 4.030

5.  Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.

Authors:  J Koch-Weser; S W Klein; L L Foo-Canto; J A Kastor; R W DeSanctis
Journal:  N Engl J Med       Date:  1969-12-04       Impact factor: 91.245

6.  Lidocaine intramuscularly in acute myocardial infarction.

Authors:  V Bernstein; M Bernstein; J Griffiths; D I Peretz
Journal:  JAMA       Date:  1972-02-21       Impact factor: 56.272

7.  Relationship between plasma propranolol concentration and relief of essential tremor.

Authors:  D Jefferson; P Jenner; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-09       Impact factor: 10.154

8.  Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure.

Authors:  L F Prescott; K K Adjepon-Yamoah; R G Talbot
Journal:  Br Med J       Date:  1976-04-17

9.  Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.

Authors:  D M Roden; S B Reele; S B Higgins; G R Wilkinson; R F Smith; J A Oates; R L Woosley
Journal:  Am J Cardiol       Date:  1980-09       Impact factor: 2.778

10.  Suppression of chronic ventricular arrhythmias with propranolol.

Authors:  R L Woosley; D Kornhauser; R Smith; S Reele; S B Higgins; A S Nies; D G Shand; J A Oates
Journal:  Circulation       Date:  1979-10       Impact factor: 29.690
View more
  9 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Amiodarone therapeutic plasma concentration monitoring. Is it practical?

Authors:  T Maling
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

3.  Antiarrhythmic drugs.

Authors:  W S Hillis; B Whiting
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-23

Review 4.  Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Authors:  P Pentel; N Benowitz
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

5.  Sustained release disopyramide compared to plain capsules after change-over from intravenous infusion.

Authors:  E Lien; O M Bakke
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

6.  Cimetidine-procainamide pharmacokinetic interaction in man: evidence of competition for tubular secretion of basic drugs.

Authors:  A Somogyi; A McLean; B Heinzow
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 7.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

Review 8.  Comparison of drug dosing methods.

Authors:  M E Burton; M R Vasko; D C Brater
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

9.  Plasma binding of disopyramide and mono-N-dealkyldisopyramide.

Authors:  J E Bredesen; E Pike; P K Lunde
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.